21
TITLE: Negative MR4.0 chronic myeloid leukaemia and its possible implications for treatment-free remission  Full Text
AUTHORS: Nuno Cerveira; Joana Diamond; Sonia Matos; Maria L Amorim; Margarida Coucelo; Susana Bizarro; Ana Teresa Simoes; Francesca Pierdomenico; Mariana Lopes; Leticia Ribeiro; Maria do Carmo Fonseca; Jose E Guimaraes; Antonio Almeida; Manuel R Teixeira ;
PUBLISHED: 2019, SOURCE: BRITISH JOURNAL OF HAEMATOLOGY, VOLUME: 186, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
22
TITLE: Less iron improves MDS haematopoiesis
AUTHORS: Gyan, E; Almeida, AM;
PUBLISHED: 2019, SOURCE: BRITISH JOURNAL OF HAEMATOLOGY, VOLUME: 187, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
23
TITLE: Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Clinical Practice  Full Text
AUTHORS: Antonio Almeida; Francesca Pierdomenico; Blanca Polo Guerrero; Filipa Saraiva; Ana Montalvao; Jorge Coutinho; Mario Mariz; Teresa Melo; Maria Joao Santos; Alexandra Pereira; Nuno Cerveira;
PUBLISHED: 2019, SOURCE: ACTA MEDICA PORTUGUESA, VOLUME: 32, ISSUE: 7-8
INDEXED IN: WOS
24
TITLE: The European Hematology Exam: The Next Step toward the Harmonization of Hematology Training in Europe
AUTHORS: Jose Tomas Navarro; Gunnar Birgegard; Janet Strivens; Wietske W G Hollegien; Naomi van Hattem; Manon T Saris; Marielle J Wondergem; Cheng Hock Toh; Antonio M Almeida;
PUBLISHED: 2019, SOURCE: HEMASPHERE, VOLUME: 3, ISSUE: 5
INDEXED IN: Scopus WOS
25
TITLE: Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available
AUTHORS: Foltz, L; Pica, GM; Zerazhi, H; Van Droogenbroeck, J; Visanica, S; de la Fuente, EB; Leber, B; de Almeida, AM; Ranta, D; Kiladjian, JJ; Chrit, L; Kandra, A; Morando, J; Devos, T;
PUBLISHED: 2019, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 60, ISSUE: 14
INDEXED IN: Scopus WOS CrossRef: 6
IN MY: ORCID
27
TITLE: Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial
AUTHORS: Guillermo Garcia-Manero; Antonio Almeida; Pierre Fenaux; Norbert Gattermann; Aristoteles Giagounidis; Stuart L Goldberg; Keiya Ozawa; Jerry Weaver; Valeria Santini;
PUBLISHED: 2019, SOURCE: Clinical Lymphoma Myeloma and Leukemia, VOLUME: 19, ISSUE: 4
INDEXED IN: CrossRef: 4
IN MY: ORCID
28
TITLE: Vorinostat synergizes with antioxidant therapy to target myeloproliferative neoplasms
AUTHORS: Bruno A Cardoso; Teresa L Ramos; Hélio Belo; Filipe Vilas-Boas; Carla Real; António M Almeida;
PUBLISHED: 2019, SOURCE: Experimental Hematology, VOLUME: 72
INDEXED IN: CrossRef: 6
IN MY: ORCID
29
TITLE: Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS  Full Text
AUTHORS: Louise de Swart; Alex Smith; Detlef Haase; Pierre Fenaux; Argiris Symeonidis; Jaroslav Cermak; Guillermo Sanz; Reinhard Stauder; Moshe Mittelman; Eva Hellstrom Lindberg; Luca Malcovati; Saskia Langemeijer; Mette Skov Holm; Krzysztof Madry; Ulrich Germing; Antonio Medina Almeida; Aurelia Tatic; Aleksandar Savic; Njetocka Gredelj Simec; Corine van Marrewijk; Agnes Guerci Bresler; Laurence Sanhes; Elisa Luno; Dominic Culligan; Odile Beyne Rauzy; Sonja Burgstaller; Nicole Blijlevens; David Bowen; Theo de Witte; ...More
PUBLISHED: 2018, SOURCE: LEUKEMIA RESEARCH, VOLUME: 67
INDEXED IN: Scopus WOS
30
TITLE: Hematology traning in Europe
AUTHORS: Almeida, A;
PUBLISHED: 2018, SOURCE: International Journal of Laboratory Hematology, VOLUME: 40, ISSUE: S1
INDEXED IN: Scopus CrossRef
IN MY: ORCID
Page 3 of 9. Total results: 86.